Table 4.
Univariate and multivariate analysis for predicting EHM in followed up patients.
| Variable | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95%CI | p-Value | HR | 95%CI | p-Value | |
| Age, years | 0.999 | 0.978-1.021 | 0.951 | |||
| Sex | ||||||
| Male | ||||||
| Female | 1.452 | 0.901–2.341 | 0.126 | |||
| History of diabetes | 0.893 | 0.549–1.452 | 0.647 | |||
| History of cirrhosis | 0.676 | 0.428–1.066 | 0.092 | |||
| History of smoke | 0.831 | 0.537–1.285 | 0.405 | |||
| History of drink | 0.756 | 0.473–1.211 | 0.245 | |||
| BMI | 0.978 | 0.915–1.046 | 0.517 | |||
| Child–Pugh | ||||||
| A | 0.256 | 0.034–1.913 | 0.184 | |||
| B | 0.300 | 0.039–2.289 | 0.245 | |||
| C | ||||||
| WBC, ×109/L | 1.063 | 0.970–1.164 | 0.192 | |||
| NE, % | 1.028 | 1.009–1.048 | 0.004 | 1.021 | 1.000–1.044 | 0.044 |
| HB, g/L | 1.000 | 0.994–1.006 | 0.930 | |||
| PLT, ×109 | 1.002 | 0.999–1.005 | 0.187 | |||
| ALT, U/L | 1.000 | 1.000–1.001 | 0.245 | |||
| AST, U/L | 1.001 | 1.000–1.001 | 0.093 | |||
| TP, g/L | 0.975 | 0.950–1.001 | 0.057 | 0.970 | 0.942–0.998 | 0.039 |
| ALB, g/L | 0.975 | 0.932–1.020 | 0.267 | |||
| GLO, g/L | 0.975 | 0.944–1.007 | 0.123 | |||
| TBIL, μmol/L | 1.002 | 0.997–1.007 | 0.376 | |||
| DBIL, μmol/L | 1.003 | 0.997–1.009 | 0.331 | |||
| ALP, U/L | 1.001 | 1.000–1.003 | 0.117 | |||
| CHE, U/L | 1.000 | 1.000–1.000 | 0.765 | |||
| INR | 1.009 | 0.970–1.049 | 0.663 | |||
| TT, s | 0.997 | 0.936–1.063 | 0.932 | |||
| DD, mg/L | 1.012 | 0.993–1.031 | 0.224 | |||
| APTT, s | 1.014 | 0.984–1.044 | 0.368 | |||
| FIB, g/L | 1.102 | 0.952–1.277 | 0.194 | |||
| PT, s | 1.015 | 0.922–1.117 | 0.765 | |||
| AFP, ng/ml | 1.000 | 1.000–1.000 | 0.309 | |||
| CA19-9 ≥35 U/ml | 1.000 | 0.999–1.001 | 0.917 | |||
| CEA ≥5 ng/ml | 6.240 | 2.832–13.747 | 0.000 | 1.281 | 1.100–1.491 | 0.001 |
| HBsAg, positive | 1.290 | 0.796–2.091 | 0.302 | |||
| Anti-HCV, positive | 0.273 | 0.037–2.016 | 0.203 | |||
| Tumor number | 1.049 | 0.892–1.235 | 0.562 | |||
| Tumor sizes, cm | 1.083 | 1.032–1.136 | 0.001 | 1.072 | 1.014–1.134 | 0.014 |
| Vascular invasion | 1.705 | 1.051–2.764 | 0.031 | |||
| Tumor location | ||||||
| Left lobe | 1.294 | 0.547–3.059 | 0.558 | |||
| Right lobe | 0.939 | 0.606–1.454 | 0.778 | |||
| Bilateral lobe | ||||||
BMI, Body Mass Index; WBC, White Blood Cell Count; NE, Neutrophil; HB, Hemoglobin; PLT, Platelet Count; ALT, Alanine Amiotransferase; AST, Aspartate Aminotransferase; TP, Total Protein; ALB, Albumin; GLO, Globulin; TBIL, Total Bilirubin; DBIL, Direct Bilirubin; ALP, Alkaline Phosphatase; Cr, Creatinine; CHE, Cholinesterase; INR, International Normalized Ratio; TT, Thrombin Time; DD, D-Dimer; APTT, Activated Partial Thromboplastin Time; FIB, Fibrinogen; PT, Prothrombin Time; AFP, α-Fetoprotein; CEA, Carcinoembryonic Antigen; CA19-9, Carbohydrate Antigen 19-9;HBsAg, Hepatitis B Surface Antigen; Anti-HCV, Anti-Hepatitis C Virus Antibody.